Molecular Culture® ID for Meningitis Diagnostics
The Challenge of Diagnosing Bacterial Infections in Cerebrospinal Fluid (CSF)
Diagnosing bacterial infections in cerebrospinal fluid is critical yet challenging, as traditional culture methods are slow and often delay crucial therapeutic decisions. These methods typically take a minimum of four days to yield results, leaving clinicians to rely on broad-spectrum antibiotics based on clinical suspicion, which increases the risk of improper treatment.
The Solution: Molecular Culture® ID.
Molecular Culture® ID provides untargeted bacterial species detection within hours, addressing the limitations of traditional cultures. This breakthrough technology enables faster and more accurate diagnostics for bacterial infections in CSF.
The Impact in Healthcare.
- Results are delivered in hours, not days.
- Detects hundreds of bacterial species, including those missed by traditional cultures.
- Reduces unnecessary antibiotic use and the associated risks of improper treatment.
Clinical Performance of Molecular Culture® ID.
A study evaluating 273 suspected meningitis cases demonstrated that Molecular Culture® ID significantly outperformed traditional culture methods. The technology’s speed and accuracy enable earlier interventions, improving patient outcomes and reducing severe morbidity and mortality.
Molecular Culture® ID detected 51 additional bacterial findings and nearly twice the species than standard culture.
Request your Starter Kit now.
We are happy to send you a free Molecular Culture® testkit to experience the benefits in practice. Contact us with the form below.
